Company profile
CalciMedica, Inc.
NASDAQ: CALC · Healthcare · Biotechnology
PublicHQ La Jolla, CACIK 0001534133Reports USD
#1 of 1,418 Healthcare companies by revenue
EA Score
——FH 17DQ —GM —SS 30
v0.1 · 35/100 weight · pillars only
↑ filing timeliness, market scale · ↓ Piotroski F, listing tenure
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$29.6M
Employees
16
as of 2026-08-21
Market cap
$9.2M
as of 2026-08-21
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Net income-$29.6M-$29.6M2025
Operating income-$23.1M-$23.1M2025
Total assets$13.6M$13.6M2025
Liabilities$20.2M$20.2M2025
Equity-$6.6M-$6.6M2025
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is CalciMedica, Inc.’s financial profile?
CalciMedica, Inc. earned -$29.6M in FY2025 net income.
Peers · Healthcare
Medicure Inc.——Skye Bioscience, Inc.——Quince Therapeutics, Inc.——CNS Pharmaceuticals, Inc.——AEON Biopharma, Inc.——AI Maverick Intel, Inc.——Key facts
CEOA. Rachel Leheny
SectorHealthcare
IndustryBiotechnology
HeadquartersLa Jolla, CA
ExchangeNASDAQ: CALC
Employees16
IPO date2023-06-14
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.